Newsroom

Press Releases

Tuesday, 07 May 2019

National Institute for Health and Care Excellence (NICE) releases Medtech Innovation Briefing (MIB) on the SEM Scanner in the UK

The SEM Scanner has received a Medtech Innovation Briefing (MIB), as part of the National Institute for Health and Care Excellence (NICE) advice in the UK. The SEM Scanner objectively alerts clinicians to specific anatomical areas of a patient’s body at increased risk for developing pressure damage, meaning patient risk assessments are performed before visible damage manifests at the skin surface – a world and clinical first.1

View press release

Wednesday, 17 April 2019

Arjo Australia sign a Joint Marketing Agreement with BBI (Europe) Ltd.

Arjo, a market-leading supplier of medical devices and solutions, today signed a Joint Marketing Agreement with BBI (Europe) Ltd allowing both companies to work together for the promotion of a Pressure Injury (PI) Prevention Solution Set combining the BBI SEM Scanner 200 and Arjo PI interventions, including specialised beds, therapeutic surfaces and patient mobility equipment, resulting in an offering that provides real preventive healthcare for those at risk of pressure injuries.

View press release

Monday, 11 March 2019

BBI wins at the North West Coast Research & Innovation Awards 2019

We are thrilled to announce that BBI, along with the SEM Scanner, has won the Patient Safety Innovation Award at this year’s North West Coast Research & Innovation Awards.

View press release

Wednesday, 06 February 2019

Arjo and BBI JMA Territory Expanded to Northern and Southern Ireland

Joint Marketing Agreement between Arjo and BBI (Europe) Ltd (Bruin Biometrics) will be expanded to include Northern & Southern Ireland.

View press release

Wednesday, 06 February 2019

BBI LLC (Bruin Biometrics) included in the Global Digital Health 100

We are delighted to announce that the BBI LLC (Bruin Biometrics) has been included in the Global Digital Health 100 list for 2018.

View press release

Wednesday, 06 February 2019

Fannon Announcement

Since 2015, Fannin Healthcare has successfully represented BBI (Europe) Limited (Bruin Biometrics) across Ireland in the promotion and sale of the company’s SEM 200 Scanner.

View press release

Thursday, 03 January 2019

FDA Grants De Novo Marketing Authorization to First-of-its-Kind Device for Objectively Assessing Patients at Risk of Pressure Ulcers

Bruin Biometrics, LLC (“BBI”) has been granted U.S. Food and Drug Administration (FDA) marketing authorization for the SEM Scanner, a wireless handheld device that is indicated for use as an adjunct to the standard of care when assessing patients who are at increased risk for pressure ulcers.

View press release

Friday, 03 August 2018

Arjo, a market-leading supplier of medical devices and solutions, has entered into a Joint Marketing Agreement with BBI

Arjo, a market-leading supplier of medical devices and solutions, has entered into a Joint Marketing Agreement with BBI LLC (Bruin Biometrics), a US based technology company, who are committed to modernising health care with biometric sensor technology for the early risk assessment and monitoring of chronic, preventable conditions in collaboration with clinicians.

View press release

Tuesday, 27 March 2018

BBI Wins Health Service Journal's 2018 Best Innovation in Medical Technology Award

SEM Scanner Also Named 2018 Most Innovative Product by Journal of Wound Care

 The Health Service Journal has named Bruin Biometrics, LLC ("BBI"), as the winner of its 2018 Best Innovation in Medical Technology Award for developing the SEM Scanner device for the early risk assessment of pressure ulcers (also known as "bed sores" or "pressure injuries").

View press release

Monday, 12 February 2018

Cutting-edge technology supports the care of terminally ill people in Newcastle through pressure ulcer risk assessment

BBI Europe Ltd have worked with Marie Curie, the UK’s leading charity for people with any terminal illness, to undertake a successful pilot scheme to improve the care and well-being of people in its specialist palliative care services at the Marie Curie Hospice, Newcastle. Through investment in state-of-the-art scanning technology (SEM Scanner) a number of terminally ill patients have been saved from the potential distress and pain that can be caused by pressure ulcer (PUs).

View press release

Tuesday, 08 August 2017

The University of Huddersfield’s Pressure Ulcer Experts Team up Bruin Biometrics Based in Los Angeles

risk assessment

The strategic alliance will focus on the use of the SEM scanner early risk assessment technology to attack the UK’s £2 billion+ health problem

<p>An innovative research collaboration between the University of Huddersfield and the Los Angeles-based medical device company Bruin Biometrics (BBI, LLC) has been revealed. <p">Experts at the University’s award-winning Institute for Skin Integrity & Infection Prevention (ISaIP) will apply their knowledge to research using BBI’s SEM Scanner technology, a handheld device that can detect pressure ulcers developing under the skin earlier than visual inspection of the skin surface.

View press release

Wednesday, 02 August 2017

Bruin Biometrics (BBI) and Isle of Wight NHS Trust Take Home UK’s Top Prize for Best Product or Innovation for Patient Safety

SEM Scanner recognized for role in transforming pressure ulcer care to save money and release productivity for a public health issue costing the NHS over £2B per annum

Manchester, UK, August 1, 2017 – At this year’s Patient Safety Awards, Bruin Biometrics and Isle of Wight NHS Trust were awarded Best Product or Innovation for Patient Safety for use of the SEM Scanner, a non-invasive device for early detection of pressure ulcers (“bedsores”), by the prestigious Health Service Journal. An estimated 18 to 25 percent of patients in acute care and long-term care settings suffer from pressure ulcers, which cost the NHS £2.1B per annum.

View press release

Tuesday, 19 July 2016

BBI to Build First Digital Surveillance System for Pressure Ulcers

Platform Combines SEM Scanner Detection with NHS-developed Pressure Ulcer Management Tool

Manchester, UK, and LOS ANGELES, July 19, 2016 – Medical device company Bruin Biometrics, LLC (“BBI”), is linking the SEM Scanner, its wireless point-of-care device for pressure ulcer risk assessment, to a digital registry for pressure ulcers known as “PUNT” (Pressure Ulcer Notification Tool) as it steps up its war on a life-threatening condition that claims as many lives in the US as most cancers. Today, pressure ulcers impact nearly 5 million patients in Europe and North America with treatment costs exceeding $13B -- nearly 500,000 of those cases occur in the United Kingdom, posing a £2.1bn problem to the NHS.

View press release

Wednesday, 06 July 2016

BBI Announces Formation of European Scientific Advisory Board to Support Advances in Woundcare and Pressure Ulcer Prevention

MANCHESTER, U.K., and LOS ANGELES, U.S.A., July 6, 2016 - Medical device company Bruin Biometrics, LLC ("BBI" ), today announced the formation of a European Scientific Advisory Board, comprised of internationally-recognized luminaries in woundcare, who will help shape the future of pressure ulcer risk assessment and build additional momentum for BBI's SEM Scanner, a handheld device for pressure ulcer detection healthcare institutions throughout the UK and Ireland are adopting.

View press release

Wednesday, 11 May 2016

Bruin Biometrics and RCSI Partner on Pressure Ulcer Prevention Research

Broad Agreement to use SEM Scanner in Translational Research to Attack £2 Billion+ Health Problem

Manchester, UK, and Dublin, IRELAND, May 11, 2016 - In a search for new ways to attack pressure ulcers – a persistent, £2 billion-plus problem throughout Ireland and the United Kingdom -- Bruin Biometrics LLC (BBI, LLC), a developer of innovative sensor-based diagnostic products, and RCSI (Royal College of Surgeons in Ireland) announced today that they have agreed to undertake a number of collaborative projects that will employ BBI's proprietary bioimpedance technology, the SEM Scanner, for the early detection and prevention of pressure ulcers.

View press release

Wednesday, 27 April 2016

BBI Begins Enrolling Pivotal Trial Evaluating SEM Scanner for the Early Detection of Pressure Ulcers

Study to Replicate Accuracy and Speed to Detection Previously Demonstrated in Pilot Study

BBI, LLC, a developer of innovative sensor-based diagnostic products, today announced the initiation of a multi-center, pivotal clinical trial to evaluate performance of the SEM Scanner in detecting early-stage pressure ulcers, as compared to today’s standard of care.

View press release

Wednesday, 17 February 2016

Virgin Care Adopts BBI's SEM Scanner as New Standard of Care for Pressure Ulcer Prevention

Decision Follows Drastic Reduction in Pressure Ulcers at Hospitals Using the Scanner

Virgin Care, an independent provider of services to NHS England, today announced that it is equipping nurses with Bruin Biometrics’ (BBI) SEM Scanner as its new standard of care for pressure ulcer detection and prevention, following a six-month pilot in which Virgin Care reduced pressure ulcers – a preventable patient safety issue costing the NHS over £2 billion per year – by approximately 95 percent, to nearly zero, with the SEM Scanner.

View press release

Thursday, 14 January 2016

BBI Receives Frost & Sullivan Award for New Product Innovation for Pressure Ulcer Diagnostics

BBI's SEM Scanner Cited as a “Revolutionary Game Changer"

BBI, LLC, a developer of innovative sensor-based diagnostic products, today announced that it has won the Frost & Sullivan European New Product Innovation Award for Pressure Ulcer Diagnostics for 2015 for the SEM Scanner, BBI’s “revolutionary” hand-held device for detecting early pressure ulcers.

View press release

Friday, 08 January 2016

BBI Completes $9 Million Series A Financing

Funding Will Support SEM Scanner Commercialization in Europe

Bruin Biometrics, LLC (“BBI”), a developer of innovative sensor-based diagnostic products, today announced the closing of a $9 million financing. The round was financed by new and existing investors.

View press release

Friday, 06 March 2015

Pioneering Skin Scanner Trial Underway

An innovative technology that detects the early signs of tissue damage is being trialled at Doncaster and Bassetlaw Hospitals NHS Foundation Trust.

View press release

FaLang translation system by Faboba